Investigating the feasibility of a new AI driven innovation that support self-management of mental wellbeing

调查支持心理健康自我管理的新人工智能驱动创新的可行性

• 批准号: 10043533
• 金额: $ 6.3万
• 依托单位: SLEEPCOGNI LIMITED
• 依托单位国家: 英国
• 项目类别: Grant for R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10043533
• 关键词: Investigating; feasibility; new; AI; driven

Mental health includes our emotional, psychological, and social well-being. It affects how we think, feel, and act. It also helps determine how we handle stress, relate to others, and make healthy choices.However, with the impact of COVID, war in Ukraine and growing economic downturn there is a growing mental health crisis which the NHS was already unable to cope with, leading to an unsustainable backlog.Our unique ring trigger device delivers our patented treatment, Active-Biofeedback, personalised by the 12 physiological, behavioural and environmental sensors. The therapy uses light, sound and tactile cues personalised through a biofeedback system to help people relax, unwind and distract from their anxieties.One in four adults' experiences at least one diagnosable mental health problem in any given year. Mental health problems represent the largest single cause of disability in the UK. The cost to the economy is estimated at £105 billion a year -- roughly the cost of the entire NHS. Anxiety Disorder market size is projected to reach $13.03bn by 2027 and stress management market is expected to reach $20.6bn by 2024\.We require funding to conduct feasibility research into the user acceptance of the innovation to support self-management of mental wellbeing due to economic downturn, rising commodity costs and reduction in global investment. The current economic climate means that there is a high risk associated with this project which there is little appetite for at this time.However, there is an urgent global clinical need to support patient suffering from mental health issues. This grant funding will allow the business to accelerate development of the stress and anxiety product at a time when mental health issues are rising - due to the exact reason why public funding is needed.

心理健康包括我们的情绪，心理和社会福祉。它会影响我们的思考、感受和行动。它还有助于我们如何处理压力，与他人相处，并做出健康的选择。然而，随着新冠肺炎的影响，乌克兰战争和日益严重的经济衰退，NHS已经无法科普日益严重的心理健康危机，导致不可持续的积压。我们独特的环形触发装置提供我们的专利治疗，主动生物反馈，个性化的12个生理，行为和环境传感器。该疗法通过生物反馈系统使用个性化的光、声音和触觉提示，帮助人们放松、放松和分散焦虑。每四个成年人中就有一个在任何一年中至少经历过一次可诊断的心理健康问题。心理健康问题是英国残疾的最大单一原因。经济成本估计为每年1050亿英镑-大致相当于整个NHS的成本。焦虑症市场规模预计到2027年将达到130.3亿美元，压力管理市场预计到2024年将达到206亿美元。由于经济衰退，商品成本上升和全球投资减少，我们需要资金进行可行性研究，以了解用户对创新的接受程度，以支持心理健康的自我管理。当前的经济环境意味着该项目存在高风险，目前对此兴趣不大。然而，全球迫切需要为患有精神健康问题的患者提供支持。这笔赠款将使企业能够在心理健康问题不断上升的时候加快压力和焦虑产品的开发-由于需要公共资金的确切原因。